文献速递主动脉疾病

钝性胸主动脉损伤的血管内修复:支架植入后高血压是偶然发现吗?

Endovascular Repair of Blunt Thoracic Aortic Trauma: Is Postimplant Hypertension an Incidental Finding?
PubMed 文献 · Ann Vasc Surg · 2018-03-07

该研究回顾了2005年1月至2016年1月在一家三级医院因钝性胸主动脉损伤接受胸主动脉腔内修复术(TEVAR)的23例患者,报告其短期和长期结局并探讨支架植入后高血压。中位随访100个月,8例(34.8%)既往无高血压的患者出现新发动脉高血压,年轻年龄(P=0.027)和左锁骨下动脉覆盖(P=0.01)被确定为潜在危险因素。作者认为TEVAR治疗钝性胸主动脉损伤安全,短期和长期并发症及死亡率低,但需更大规模队列研究阐明支架植入后高血压的机制。

要点

  • 23例钝性胸主动脉损伤患者接受TEVAR,100%成功完全隔绝损伤,30天死亡率和并发症率分别为4.3%和8.7%。
  • 8例(34.8%)既往无高血压患者出现新发动脉高血压,年轻年龄(P=0.027)和左锁骨下动脉覆盖(P=0.01)为潜在危险因素。
  • 中位随访100个月,6例仍需降压治疗,2例无需永久治疗。

核心结论

  • TEVAR是治疗钝性胸主动脉损伤的安全方法,短期和长期并发症及死亡率低。
  • 较低年龄和左锁骨下动脉覆盖可能促进支架植入后高血压的发生。
  • 需要进一步更大规模队列研究以阐明支架植入后高血压的潜在机制。

研究设计与样本

  • 回顾性研究,纳入2005年1月至2016年1月在一家三级医院因钝性胸主动脉损伤接受TEVAR的23例患者。
  • 患者中位年龄44岁(范围18-73岁),14例(60.9%)诊断为主动脉破裂,9例(39.1%)为假性动脉瘤。
  • 21例患者置入单个胸主动脉支架,其余2例置入2个支架。

主要发现

  • 所有患者均实现损伤完全隔绝(100%初次成功)。
  • 6例(26%)患者故意覆盖左锁骨下动脉(SCA)。
  • 术中并发症包括1例非致死性卒中经保守治疗和1例髂外动脉破裂经髂股旁路治疗。
  • 1例(4.3%)患者术后第1天在重症监护室(ICU)因失血性休克死亡;总体30天死亡率和并发症率分别为4.3%和8.7%。
  • 8例(34.8%)既往无高血压患者出现新发支架植入后动脉高血压;年轻年龄(P=0.027)和SCA覆盖(P=0.01)被确定为潜在危险因素,而合并损伤(P=0.3)和术中并发症(P=0.1)则不是。

局限性

  • 需要进一步更大规模队列研究以阐明支架植入后高血压的潜在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blunt thoracic aortic injury (BTAI) is the second most common cause of death in trauma patients. Nowadays, thoracic endovascular aortic repair (TEVAR) has become the treatment of choice because of lower rates of mortality, paraplegia, and stroke. However, concerns have been raised whether graft implantation is related to the development of hypertension in the postoperative period. The aim of this study was to report short- and long-term outcomes of patients undergoing TEVAR for BTAIs at a tertiary hospital and to investigate postimplant hypertension. METHODS: Between January 2005 and January 2016, 23 patients with blunt thoracic aortic trauma underwent TEVAR. Median age was 44 years (range, 18-73). Among them, 14 (60.9%) patients were diagnosed with aortic rupture, whereas 9 (39.1%) with pseudoaneurysm. Α single thoracic stent graft was deployed in 21 patients, and the rest 2 patients received 2 stent grafts. RESULTS: Complete exclusion of the injury was feasible in all subjects (100% primary success). The left subclavian artery (SCA) was intentionally covered in 6 patients (26%). Intraoperative complications included one nonfatal stroke managed conservatively and one external iliac artery rupture treated with iliofemoral bypass. One patient (4.3%) died on the first postoperative day in the intensive care unit (ICU) because of hemorrhagic shock. The overall 30-day mortality and morbidity were 4.3% and 8.7%, respectively. New-onset postimplantation arterial hypertension was observed in 8 (34.8%) previously nonhypertensive patients. Younger age (P = 0.027) and SCA coverage (P = 0.01) were identified as potential risk factors for the development of postimplant hypertension, whereas the presence of concomitant injuries (P = 0.3) and intraoperative complications (P = 0.1) were not. After a median follow-up of 100 months (range, 18-120), 6 of them still remain on antihypertensive therapy, whereas the other 2 did not require permanent treatment. CONCLUSIONS: TEVAR is a safe approach in the treatment of BTAI associated with low short- and long-term morbidity and mortality rates. Lower age and SCA coverage may contribute to the development of postimplant hypertension. Further larger cohort studies are warranted to elucidate the underlying mechanisms of postimplant hypertension.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tigkiropoulos K, Sigala F, Tsilimigras DI, et al. Endovascular Repair of Blunt Thoracic Aortic Trauma: Is Postimplant Hypertension an Incidental Finding? Ann Vasc Surg. 2018. PMID: 29524462. doi:10.1016/j.avsg.2018.01.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。